You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

FFA

Showing 1 - 25 of 527
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Familial Adenomatous Polyposis Trial in Bologna (Eicosapentaenoic acid free fatty acid (EPA-FFA), Placebo)

Recruiting
  • Familial Adenomatous Polyposis
  • Eicosapentaenoic acid free fatty acid (EPA-FFA)
  • Placebo
  • Bologna, Italy
    University of Bologna and St.Orsola-Malpighi Hospital
Oct 26, 2022

Lichen Planopilaris Trial in Scottsdale, Jacksonville (Deucravacitinib)

Not yet recruiting
  • Lichen Planopilaris
  • Scottsdale, Arizona
  • +1 more
Oct 16, 2023

Splanchnic and Systemic VLDL-TG and FFA Balance

Completed
  • NAFLD
  • NASH - Nonalcoholic Steatohepatitis
    • Skejby, Aarhus N, Denmark
      Arhus University Hospital Department of Endocrinology and Intern
    May 23, 2022

    Multiple Sclerosis, Relapsing-Remitting Trial in Munich, Mainz, Münster (Vivomixx®, Conjugated linoleic acid (CLA/Tonalin® FFA

    Not yet recruiting
    • Multiple Sclerosis, Relapsing-Remitting
    • Vivomixx®
    • +3 more
    • Munich, Bavaria, Germany
    • +2 more
    Jun 15, 2023

    Prevalence of Diabetic Retinopathy in Type 2 Diabetic Patients

    Not yet recruiting
    • Diabetic Retinopathy
    • Optical Coherence Tomography (OCT)
    • Fundus fluorescein angiography (FFA)
    • (no location specified)
    Nov 24, 2023

    Dental Malocclusion, Angle Class II, Angle Class I Trial in Buffalo (BRIUS)

    Completed
    • Dental Malocclusion
    • +3 more
    • BRIUS
    • Buffalo, New York
      Department of Orthodontics, School of Dental Medicine, SUNY at B
    Sep 2, 2022

    SARS-CoV-2 Trial in Spain, United Kingdom (Eicosapentaenoic acid gastro-resistant capsules, Placebo)

    Recruiting
    • SARS-CoV-2
    • Eicosapentaenoic acid gastro-resistant capsules
    • Placebo
    • Barcelona, Spain
    • +4 more
    Nov 26, 2021

    Optical Coherence Tomography Angiography and in Fluorescein

    Not yet recruiting
    • OctA .FFA Findings in DR
    • OCTAngiography .FFangiography
    • (no location specified)
    Dec 29, 2021

    Healthy Trial in Rochester (Somatostatin, Dextrose, Insulin)

    Suspended
    • Healthy
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 31, 2022

    Uric Acid Nephrolithiasis Trial in Dallas (123I-BMIPP, 99mTc-MAG3)

    Withdrawn
    • Uric Acid Nephrolithiasis
    • 123I-BMIPP
    • 99mTc-MAG3
    • Dallas, Texas
    • +1 more
    Oct 1, 2020

    Breastcancer Trial in San Antonio (Omega-3 FFA)

    Completed
    • Breastcancer
    • Omega-3 FFA
    • San Antonio, Texas
      CTRC at University of Texas Health Science Center San Antonio
    Mar 15, 2021

    Polycystic Ovary Syndrome Trial in Sherbrooke (Rosiglitazone, Acarbose)

    Completed
    • Polycystic Ovary Syndrome
    • Sherbrooke, Quebec, Canada
      Université de Sherbrooke
    Jan 4, 2022

    Influenza A Trial in Hong Kong (FFA, clarithromycin, oseltamivir, Oseltamivir alone)

    Unknown status
    • Influenza A
    • FFA, clarithromycin, oseltamivir
    • Oseltamivir alone
    • Hong Kong, Hong Kong
      Ivan Hung
    Oct 21, 2019

    Obstructive Sleep Apnea, Obesity Trial in Prague (Dietary and physical intervention)

    Recruiting
    • Obstructive Sleep Apnea
    • Obesity
    • Dietary and physical intervention
    • Prague, Czechia
      University Hospital Královské Vinohrady
    Feb 15, 2022

    Type 2 Diabetes, Dyslipidemia Trial (Metformin, Placebo)

    Completed
    Has Results
    • Type 2 Diabetes
    • Dyslipidemia
    • (no location specified)
    Sep 24, 2019

    Retinopathy of Prematurity Trial (Diode laser photocoagulation.)

    Not yet recruiting
    • Retinopathy of Prematurity
    • Diode laser photocoagulation.
    • (no location specified)
    Sep 16, 2023

    Morning Versus Afternoon Aerobic Exercise in Type 1 Diabetes

    Not yet recruiting
    • Type1diabetes
    • Morning exercise
    • Afternoon exercise
    • (no location specified)
    Nov 2, 2023

    Caries,Dental Trial in Buenos Aires (Fluoride)

    Completed
    • Caries,Dental
    • Fluoride
    • Buenos Aires, Caba, Argentina
      Universidad de Buenos Aires
    Apr 11, 2023

    Hypertriglyceridemia, Glucose Intolerance Trial in Pisa (20% Intralipid, Normal Saline)

    Completed
    • Hypertriglyceridemia
    • Glucose Intolerance
    • 20% Intralipid
    • Normal Saline
    • Pisa, PI, Italy
      Azienda Ospedaliero-Universitaria Pisana
    Jan 4, 2022

    Neovascular Age-related Macular Degeneration Trial in Suzhou (Aflibercept Ophthalmic, IBI302)

    Not yet recruiting
    • Neovascular Age-related Macular Degeneration
    • Aflibercept Ophthalmic
    • IBI302
    • Suzhou, Jiangsu, China
      Innovent Biologics (Suzhou) Co,Ltd.
    Jul 25, 2023

    Type 2 Diabetes Trial in Nanjing (Mulberry Twig Alkaloid Tablet, Canagliflozin)

    Active, not recruiting
    • Type 2 Diabetes Mellitus
    • Nanjing, China
      Jianhua Ma
    May 3, 2023

    Age-Related Macular Degeneration Trial in Malvern, Saint Albans (BBC1501)

    Not yet recruiting
    • Age-Related Macular Degeneration
    • Malvern, Victoria, Australia
    • +1 more
    Apr 5, 2023

    Obesity Trial (Kimchi, Placebo)

    Not yet recruiting
    • Obesity
    • Kimchi
    • Placebo
    • (no location specified)
    Jun 9, 2023

    Bilirubin Encephalopathy Trial in Houston (usual prescribed intralipid (UL) regimen, restricted prescribed intralipid (RL)

    Recruiting
    • Bilirubin Encephalopathy
    • usual prescribed intralipid (UL) regimen
    • restricted prescribed intralipid (RL) regimen
    • Houston, Texas
      The University of Texas Health Science Center at Houston
    Oct 17, 2022

    Hyperinsulinemia, Insulin Resistance, Non-Alcoholic Fatty Liver Disease Trial in New York (Diazoxide oral suspension, 1 mg per

    Recruiting
    • Hyperinsulinemia
    • +3 more
    • Diazoxide oral suspension, 1 mg per kg per dose
    • +3 more
    • New York, New York
      Columbia University Irving Medical Center
    Feb 6, 2023